STADA Arzneimittel AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

World News: . []

STADA Arzneimittel AG

05.10.2018 / 14:30
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Notification of Major Holdings

1. Details of issuer
STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Germany

2. Reason for notification
  Acquisition/disposal of shares with voting rights
X Acquisition/disposal of instruments
  Change of breakdown of voting rights
  Other reason:

3. Details of person subject to the notification obligation
Name: City and country of registered office:
Cinven Capital Management (VI) General Partner Limited Saint Peter Port, Guernsey
Channel Islands

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
Nidda Healthcare GmbH

5. Date on which threshold was crossed or reached:
28 Sep 2018

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
total of both in %
(7.a. + 7.b.)
total number of voting rights of issuer
Resulting situation 65.31 % 12.06 % 77.38 % 62342440
Previous notification 64.50 % 0 % 64.50 % /

7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 33, 34 WpHG)
ISIN absolute in %
  direct
(Sec. 33 WpHG)
indirect
(Sec. 34 WpHG)
direct
(Sec. 33 WpHG)
indirect
(Sec. 34 WpHG)
DE0007251803 40716344 % 65.31 %
Total 40716344 65.31 %

b.1. Instruments according to Sec. 38 para. 1 No. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
Tender under domination and profit and loss transfer agreement 15.10.2018 300 0.0005 %
    Total 300 0.0005 %

b.2. Instruments according to Sec. 38 para. 1 No. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
Irrevocable / purchase option Physical 7521209 12.06 %
      Total 7521209 12.06 %

8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more)
Cinven Capital Management (VI) General Partner Limited % % %
Cinven Capital Management (VI) Limited Partnership Incorporated % % %
Sixth Cinven Fund (No. 1) Limited Partnership % % %
Ciddan S.à r.l. % % %
Nidda Topco S.à r.l. % % %
Nidda Midco S.à r.l. % % %
Nidda German Topco GmbH % % %
Nidda German Midco GmbH % % %
Nidda BondCo GmbH % % %
Nidda Healthcare Holding GmbH % % %
Nidda Healthcare GmbH 65.31 % 12,06 % 77.38 %
 
Cinven Capital Management (VI) General Partner Limited % % %
Cinven Capital Management (VI) Limited Partnership Incorporated % % %
Sixth Cinven Fund (No. 2) Limited Partnership % % %
Ciddan S.à r.l. % % %
Nidda Topco S.à r.l. % % %
Nidda Midco S.à r.l. % % %
Nidda German Topco GmbH % % %
Nidda German Midco GmbH % % %
Nidda BondCo GmbH % % %
Nidda Healthcare Holding GmbH % % %
Nidda Healthcare GmbH 65.31 % 12,06 % 77.38 %
 
Cinven Capital Management (VI) General Partner Limited % % %
Cinven Capital Management (VI) Limited Partnership Incorporated % % %
Sixth Cinven Fund (No. 3) Limited Partnership % % %
Ciddan S.à r.l. % % %
Nidda Topco S.à r.l. % % %
Nidda Midco S.à r.l. % % %
Nidda German Topco GmbH % % %
Nidda German Midco GmbH % % %
Nidda BondCo GmbH % % %
Nidda Healthcare Holding GmbH % % %
Nidda Healthcare GmbH 65.31 % 12,06 % 77.38 %
 
Cinven Capital Management (VI) General Partner Limited % % %
Cinven Capital Management (VI) Limited Partnership Incorporated % % %
Sixth Cinven Fund (No. 4) Limited Partnership % % %
Ciddan S.à r.l. % % %
Nidda Topco S.à r.l. % % %
Nidda Midco S.à r.l. % % %
Nidda German Topco GmbH % % %
Nidda German Midco GmbH % % %
Nidda BondCo GmbH % % %
Nidda Healthcare Holding GmbH % % %
Nidda Healthcare GmbH 65.31 % 12,06 % 77.38 %
 

9. In case of proxy voting according to Sec. 34 para. 3 WpHG

Date of general meeting:
Holding position after general meeting: % (equals voting rights)

10. Other explanatory remarks:
 



05.10.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Read More: LINK 

Published: .

Search for other references to "stada" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us